The study aims to evaluate the reduction in severity and progression of lung injury with
inhaled ibuprofen in patients with severe acute respiratory syndrome due to SARS-CoV-2 virus.
Phase:
N/A
Details
Lead Sponsor:
Química Luar SRL
Collaborators:
Centro de Excelencia en Productos y Procesos Córdoba National Council of Scientific and Technical Research, Argentina